{"id":143,"date":"2021-07-20T14:38:18","date_gmt":"2021-07-20T18:38:18","guid":{"rendered":"https:\/\/echopaincanada.ca\/?page_id=143"},"modified":"2024-02-11T15:11:21","modified_gmt":"2024-02-11T20:11:21","slug":"echo-british-columbia","status":"publish","type":"page","link":"https:\/\/echopaincanada.ca\/fr\/echo-british-columbia\/","title":{"rendered":"ECHO Colombie Britannique"},"content":{"rendered":"
<\/div>\n\n\n\n

C.-B. ECHO pour la Douleur Chronique<\/h2>\n\n\n\n
#<\/strong><\/td>Date<\/strong><\/td>Sujet<\/strong><\/td>Objectifs d\u2019apprentissage<\/strong><\/td><\/tr><\/thead>
1<\/td>28-Sept-22<\/td>Le r\u00f4le de la neuromodulation dans la gestion de la douleur<\/td>Identifier le m\u00e9canisme d\u2019action de la neuromodulation, les diff\u00e9rents types disponibles pour les patients et les effets ind\u00e9sirables. Appliquer les directives cliniques pour s\u00e9lectionner les patients appropri\u00e9s pour la neuromodulation. D\u00e9crire le processus de r\u00e9f\u00e9rence pour la neuromodulation en Colombie-Britannique.<\/td><\/tr>
2<\/td>26-Oct-22<\/td>\u00c9valuation et prise en charge du syndrome douloureux psychosomatique<\/td>D\u00e9finir la somatisation et identifier les patients pr\u00e9sentant un risque \u00e9lev\u00e9 de somatisation. R\u00e9fl\u00e9chir aux attitudes et syndromes douloureux psychosomatiques et les croyances sur les troubles des sympt\u00f4mes somatiques.<\/td><\/tr>
3<\/td>23-Nov-22<\/td>Gestion de la douleur chez les personnes handicap\u00e9es<\/td>\u00c9valuer les syndromes douloureux sp\u00e9cifiques qui peuvent se d\u00e9velopper chez les patients handicap\u00e9s (y compris la blessure de la moelle \u00e9pini\u00e8re, accident vasculaire c\u00e9r\u00e9bral, commotion c\u00e9r\u00e9brale\/l\u00e9sion c\u00e9r\u00e9brale acquise). Expliquer comment optimiser la gestion de la douleur chez les personnes handicap\u00e9es.<\/td><\/tr>
4<\/td>13-d\u00e9c-22<\/td>Douleur et nutrition<\/td>Identifier le r\u00f4le de la nutrition dans la gestion de la douleur. Identifier les r\u00e9gimes alimentaires qui peuvent avoir un impact n\u00e9gatif sur la\ndouleur\/inflammation. \u00c9num\u00e9rer les strat\u00e9gies et les ressources di\u00e9t\u00e9tiques courantes qui peuvent exercer une influence directe sur la douleur.<\/td><\/tr>
5<\/td>25-janv-23<\/td>Traitement de la fibromyalgie avec la psychoth\u00e9rapie <\/td>Identifier les sympt\u00f4mes psychologiques courants qui sont souvent pr\u00e9sents chez les personnes atteintes de la fibromyalgie. Reconna\u00eetre les modalit\u00e9s psychoth\u00e9rapeutiques fond\u00e9es sur des donn\u00e9es probantes qui am\u00e9liorent la fonction et les sympt\u00f4mes chez les personnes atteintes de la fibromyalgie. Discuter les strat\u00e9gies d\u2019activation comportementale qui ont fait preuves d\u2019am\u00e9liorer les sympt\u00f4mes de la fibromyalgie. <\/td><\/tr>
6<\/td>22-f\u00e9v-23<\/td>Consid\u00e9rations particuli\u00e8res sur\nl\u2019\u00e9valuation et la gestion de la douleur chez les personnes \u00e2g\u00e9es <\/td>Reconna\u00eetre la multimorbidit\u00e9 et les d\u00e9fis complexes chez les personnes \u00e2g\u00e9es souffrant de douleur. Identifier les consid\u00e9rations particuli\u00e8res pour l'\u00e9valuation de la douleur chez les personnes \u00e2g\u00e9es (p. ex. cognitives, communication non verbale). Discuter la pharmacoth\u00e9rapie pour la douleur et les consid\u00e9rations particuli\u00e8res pour \u00e9quilibrer les avantages par rapport aux m\u00e9faits chez les personnes \u00e2g\u00e9es, y compris les opportunit\u00e9s et les bienfaits de la d\u00e9prescription. <\/td><\/tr>
7<\/td>22-mars-23<\/td>\u00c9valuation et prise en charge des syndromes de douleur abdominale chronique <\/td>Discuter l'\u00e9valuation clinique et les diagnostics diff\u00e9rentiels des syndromes de douleur abdominale chronique. Identifier les strat\u00e9gies de prise en charge fond\u00e9es sur des donn\u00e9es probantes pour les douleurs abdominales chroniques (p. ex. r\u00e9adaptation, strat\u00e9gies pharmacologiques et interventionnelles).<\/td><\/tr>
8<\/td>26-avr-23<\/td>Traiter les traumatismes chez les personnes souffrant de douleur chronique <\/td>Expliquer la neurobiologie du traumatisme, y compris la relation entre le traumatisme et la douleur. D\u00e9finir les soins inform\u00e9s sur les traumatismes et la violence (TVIC) et discuter comment ceux-ci peuvent aider les personnes souffrant de douleur. Identifier les obstacles associ\u00e9s aux soins de la douleur chez les personnes ayant subi un traumatisme et discuter les d\u00e9marches que les fournisseurs des soins de sant\u00e9 peuvent suivre en mati\u00e8re de soins de sant\u00e9 pour surmonter ces obstacles. <\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
<\/div>\n\n\n\n

C.-B. ECHO pour la Douleur Chronique -Site Web<\/h2>\n\n\n\n
\"\"<\/figure>\n\n\n\n
<\/div>\n\n\n\n
\n
Visitez C.-B. ECHO pour la Douleur Chronique\n(Vancouver, Colombie-Britannique)<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>","protected":false},"excerpt":{"rendered":"

BC ECHO for Chronic Pain \u2013 Curriculum # Date Topic Learning Objectives 1 28-Sept-22 The role of neuromodulation in pain management Identify the mechanism of action of neuromodulation, the different types that are available for patients, and adverse effects. Apply clinical guidelines to select appropriate patients for referral for neuromodulation. Describe the referral process for […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-143","page","type-page","status-publish","hentry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"echo_pain_ca_admin","author_link":"https:\/\/echopaincanada.ca\/fr\/blog\/author\/echo_pain_ca_admin\/"},"uagb_comment_info":0,"uagb_excerpt":"BC ECHO for Chronic Pain \u2013 Curriculum # Date Topic Learning Objectives 1 28-Sept-22 The role of neuromodulation in pain management Identify the mechanism of action of neuromodulation, the different types that are available for patients, and adverse effects. Apply clinical guidelines to select appropriate patients for referral for neuromodulation. Describe the referral process for…","_links":{"self":[{"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/pages\/143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/comments?post=143"}],"version-history":[{"count":12,"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/pages\/143\/revisions"}],"predecessor-version":[{"id":613,"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/pages\/143\/revisions\/613"}],"wp:attachment":[{"href":"https:\/\/echopaincanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}